Development of Personalized Combination Cancer Immunotherapy Based on the Patients’ Immune Status
Fig. 20.1 Mechanisms for the differential immune status among cancer patients. Balance of the anti-tumor T cell induction pathway and immunosuppressive pathway along with environmental factors may define the differences…